Cannabis Law Report

AUGUST 21, 2019

In November 2018, the legal status of cannabis was changed to allow specialist clinicians to legally prescribe cannabis-derived medicinal products to patients with an exceptional clinical need, following a high-profile media campaign. Pro-cannabis charities for individuals suffering debilitating illnesses have also reacted angrily.

Clinical Trials 81

Clinical Trials Nerve Pain Medicine Epilepsy 81

Weedistry

JANUARY 28, 2019

It’s when presented with personal stories like that of the Rhodes family and the stream of alarming data that the significance of Tetra Bio-Pharma’s (TBP) clinical trials is worth exploring. “The data also indicate that fentanyl and other fentanyl-related substances continue to be a major driver of this crisis,” Health Canadanotes.

Clinical Trials 40

Clinical Trials Research and Development Chronic Pain Data 40

Cannabis Law Report

JULY 24, 2019

1 We have also reviewed your social media websites at www.facebook.com/CuraleafHemp External Link Disclaimer and [link] External Link Disclaimer ; these websites direct consumers to your website, [link] External Link Disclaimer , to purchase your products. Chronic or arthritic pain.”. Chronic pain.

CBD 51

CBD Tincture Pets Chronic Pain 51

Cannabis Law Report

DECEMBER 20, 2021

(“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing product candidates for pain management, CNS disorders and anti-viral indications, signed a clinical trial agreement with Altasciences Company, Inc., Media: Laura Radocaj. Chipman, CPA. Chief Financial Officer. Investor Relations: Betsy Brod.

Clinical Trials 52

Clinical Trials Chronic Pain Pharmaceutical Data 52

The Cannigma

JUNE 24, 2021

The constant distractions, notifications, and social media outrages of the day can also boost your anxiety and stress, and make it much harder to just live in the moment. Both THC and CBD rich products may help those suffering from pain lasting several months.

CBD 75

CBD Microdosing Edibles Sleep 75

Cannabis Law Report

NOVEMBER 10, 2021

The NIH has also engaged a firm to manufacture Leu-enkephalin (L-ENK), the active ingredient in Envelta and a firm to manufacture the Molecular Envelope Technology (MET) that is used to carry the L-ENK to the brain to promptly suppress pain. Media: Laura Radocaj. In October 2021, Virpax announced that a $1.87 Christopher M. Betsy Brod.

Research and Development 52

Research and Development Chronic Pain Pharmaceutical Clinical Trials 52

Cannabis Law Report

DECEMBER 8, 2021

Charles River Laboratories, a renowned CRO engaged by Virpax to perform Food and Drug Administration (FDA) required pre-clinical studies, has completed a single dose pharmacokinetic study of dermal administration of Epoladerm in minipigs as part of the required Investigational New Drug Application (“IND”) enabling trials.

Clinical Trials 52

Clinical Trials Chronic Pain Pharmaceutical Topical 52

Cannabis Law Report

DECEMBER 28, 2021

Upon completion of all the required IND enabling studies and subsequent review by the FDA, Virpax intends to conduct a Phase 1 study to evaluate the relative bioavailability and pharmacokinetics of Epoladerm™ Virpax recently announced the execution of a clinical trial agreement with Altasciences Company, Inc., Chipman, CPA.

Pharmaceutical 52

Pharmaceutical Research and Development Clinical Trials Chronic Pain 52

Puff Puff Post

SEPTEMBER 16, 2019

Media are invited to attend an open house to learn more about the program and visit the recently expanded Santé Cannabis clinic and research centre in Montréal including a guided tour. RSVP: If you’d like to attend, please RSVP with Lilia Rassoul ( media@santecannabis.ca ). Time: 9:00AM to 5:00PM. ABOUT SANTÉ CANNABIS.

Programs 108

Programs Research and Development Education Treatment 108

Cannabis Law Report

NOVEMBER 24, 2021

Media representations can offer insights into the nature of the discourse about new medical products and therapies and how ideas and understandings about social phenomena become constructed. This article analyses media representations of medicinal cannabis in Australian medical publications. Media framing of cannabis.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

JULY 12, 2019

The opening of London’s first such clinic follows the opening of Britain’s first medical cannabis clinic in Greater Manchester earlier in the year. Access is clearly in demand from Londoners as there is already a waiting list of 150 patients at the London clinic ahead of its opening.

Epilepsy 40

Epilepsy Medicine Clinical Trials Chronic Pain 40

Puff Puff Post

SEPTEMBER 16, 2019

Media are invited to attend an open house to learn more about the program and visit the recently expanded Santé Cannabis clinic and research centre in Montréal including a guided tour. RSVP: If you’d like to attend, please RSVP with Lilia Rassoul ( media@santecannabis.ca ). Time: 9:00AM to 5:00PM. ABOUT SANTÉ CANNABIS.

Programs 40

Programs Research and Development Education Treatment 40

The Cannigma

APRIL 8, 2021

That there’s not enough information about, there’s not enough clinical trials, and there’s not enough this and that. They get pumped out through the media and everybody’s talking about how dangerous it is. But really, what we’re talking about is, individuals who are chronically using cannabis and we’re not distinguishing.

Medicine 108

Medicine Cannabinoids Cannabis THC 108

The Blunt Truth

FEBRUARY 17, 2023

MEDICAL MARIJUANA FOR VETS Could veterans suffering from PTSD or chronic pain be able to use cannabis to relieve their symptoms? The company is the first social media platform to permit such ads , and they come with many restrictions on type of content. We have an update on those SAFE Banking talks.

Clinical Trials 96

Clinical Trials Banking Chronic Pain Media 96